002022 科华生物
已收盘 08-14 15:00:00
资讯
新帖
简况
科华生物(002022)披露2026年限制性股票激励计划首次授予激励对象名单公示情况说明及核查意见,8月13日股价上涨0.18%
证券之星 · 08-13 22:42
科华生物(002022)披露2026年限制性股票激励计划首次授予激励对象名单公示情况说明及核查意见,8月13日股价上涨0.18%
股市必读:科华生物(002022)8月12日董秘有最新回复
证券之星 · 08-13 01:48
股市必读:科华生物(002022)8月12日董秘有最新回复
科华生物:持续推进全价值链降本增效
证券之星 · 08-12 16:09
科华生物:持续推进全价值链降本增效
股市必读:科华生物新发布《关于产品获得医疗器械注册证的公告》
证券之星 · 08-07
股市必读:科华生物新发布《关于产品获得医疗器械注册证的公告》
科华生物(002022)披露产品获得医疗器械注册证公告,8月5日股价下跌0.96%
证券之星 · 08-05
科华生物(002022)披露产品获得医疗器械注册证公告,8月5日股价下跌0.96%
连续三年亏损叠加股价较高点最大跌幅超八成,科华生物拟推股权激励计划和员工持股计划
每日经济新闻 · 08-05
连续三年亏损叠加股价较高点最大跌幅超八成,科华生物拟推股权激励计划和员工持股计划
股市必读:科华生物新发布《2026年限制性股票激励计划考核管理办法》
证券之星 · 08-05
股市必读:科华生物新发布《2026年限制性股票激励计划考核管理办法》
科华生物(002022)披露2026年限制性股票激励计划(草案),8月3日股价上涨1.38%
证券之星 · 08-03
科华生物(002022)披露2026年限制性股票激励计划(草案),8月3日股价上涨1.38%
科华生物(002022)披露“科华转债”到期兑付结果及股本变动公告,7月28日股价上涨1.41%
证券之星 · 07-28
科华生物(002022)披露“科华转债”到期兑付结果及股本变动公告,7月28日股价上涨1.41%
科华生物(002022)披露“科华转债”到期兑付及摘牌公告,7月20日股价下跌0.97%
证券之星 · 07-20
科华生物(002022)披露“科华转债”到期兑付及摘牌公告,7月20日股价下跌0.97%
科华生物:预计2026年1-6月扣非后净利润亏损9300万元至1.28亿元
证券之星 · 07-14
科华生物:预计2026年1-6月扣非后净利润亏损9300万元至1.28亿元
科华生物(002022)披露产品获得医疗器械注册证公告,7月3日股价上涨2.95%
证券之星 · 07-03
科华生物(002022)披露产品获得医疗器械注册证公告,7月3日股价上涨2.95%
科华生物(002022.SZ):补体C1q测定试剂盒(胶乳免疫比浊法)获得医疗器械注册证
智通财经 · 07-03
科华生物(002022.SZ):补体C1q测定试剂盒(胶乳免疫比浊法)获得医疗器械注册证
科华生物(002022)披露产品获得医疗器械注册证的公告,7月1日股价上涨3.49%
证券之星 · 07-01
科华生物(002022)披露产品获得医疗器械注册证的公告,7月1日股价上涨3.49%
科华生物(002022)披露“科华转债”即将到期及停止交易的第三次提示性公告,6月26日股价下跌3.36%
证券之星 · 06-26
科华生物(002022)披露“科华转债”即将到期及停止交易的第三次提示性公告,6月26日股价下跌3.36%
科华生物(002022)披露“科华转债”即将到期及停止交易的第二次提示性公告,6月24日股价下跌3.16%
证券之星 · 06-24
科华生物(002022)披露“科华转债”即将到期及停止交易的第二次提示性公告,6月24日股价下跌3.16%
科华生物:西安天隆科技为公司合并报表范围内控股子公司
证券之星 · 06-23
科华生物:西安天隆科技为公司合并报表范围内控股子公司
科华生物(002022)披露“科华转债”即将到期及停止交易的第一次提示性公告,6月22日股价下跌0.81%
证券之星 · 06-22
科华生物(002022)披露“科华转债”即将到期及停止交易的第一次提示性公告,6月22日股价下跌0.81%
股市必读:科华生物(002022)6月18日董秘有最新回复
证券之星 · 06-22
股市必读:科华生物(002022)6月18日董秘有最新回复
每周股票复盘:科华生物(002022)主体信用等级被下调至A
证券之星 · 06-21
每周股票复盘:科华生物(002022)主体信用等级被下调至A
加载更多
公司概况
公司名称:
上海科华生物工程股份有限公司
所属行业:
医药制造业
上市日期:
2004-07-21
主营业务:
上海科华生物工程股份有限公司的主营业务是体外诊断试剂、仪器的研发、生产和销售。公司的主要产品是体外诊断试剂、仪器。公司及子公司曾获得“国家科技进步二等奖”“国家高新技术企业”“国家知识产权示范企业”“国家发改委生物医学工程高技术产业化示范企业”“中国中小企业创新100强”“上海市著名商标证书”“上海名牌”“上海市科学技术奖”“上海市创新型企业”“陕西省和西安市创新型企业”“陕西省院士工作站”等荣誉,并多次入选上海百强企业多项榜单。
发行价格:
11.12
{"stockData":{"symbol":"002022","market":"SZ","secType":"STK","nameCN":"科华生物","latestPrice":5.68,"timestamp":1786691001000,"preClose":5.65,"halted":0,"volume":8247561,"delay":0,"changeRate":0.0053,"floatShares":513999999,"shares":513999999,"eps":-1.414,"marketStatus":"已收盘","change":0.03,"latestTime":"08-14 15:00:00","open":5.63,"high":5.74,"low":5.59,"amount":46756000,"amplitude":0.0265,"askPrice":5.68,"askSize":433,"bidPrice":5.67,"bidSize":10,"shortable":0,"etf":0,"ttmEps":-1.414,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786930200000},"marketStatusCode":5,"adr":0,"adjPreClose":5.65,"symbolType":"stock","openAndCloseTimeList":[[1786671000000,1786678200000],[1786683600000,1786690800000]],"highLimit":6.22,"lowLimit":5.09,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":514397174,"isCdr":false,"pbRate":1.15,"roa":"--","roe":"--","epsLYR":-1.4235,"committee":-0.698874,"marketValue":2922000000,"turnoverRate":0.016,"status":0,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2026-08-17。","floatMarketCap":2921000000},"requestUrl":"/m/hq/s/002022/","defaultTab":"news","newsList":[{"id":"2659163194","title":"科华生物(002022)披露2026年限制性股票激励计划首次授予激励对象名单公示情况说明及核查意见,8月13日股价上涨0.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659163194","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659163194?lang=zh_cn&edition=full","pubTime":"2026-08-13 22:42","pubTimestamp":1786632136,"startTime":"0","endTime":"0","summary":"近日,上海科华生物工程股份有限公司披露《董事会薪酬与考核委员会关于2026年限制性股票激励计划首次授予激励对象名单的公示情况说明及核查意见》。公告显示,公司于2026年8月3日召开第十届董事会第二十二次会议,审议通过《关于<2026年限制性股票激励计划(草案)>及摘要的议案》。公司对首次授予激励对象的姓名和职务在内部公示栏进行了公示,公示时间为2026年8月4日至8月13日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300040027.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0028","BK0188","002022","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659046349","title":"股市必读:科华生物(002022)8月12日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2659046349","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659046349?lang=zh_cn&edition=full","pubTime":"2026-08-13 01:48","pubTimestamp":1786556895,"startTime":"0","endTime":"0","summary":"截至2026年8月12日收盘,科华生物报收于5.64元,上涨2.55%,换手率1.61%,成交量8.28万手,成交额4627.19万元。董秘最新回复投资者: 成本领先战略:通过大规模、高效率把成本做到行业最低。未来IVD行业只有以上3种企业能生存,董秘或董事会觉得贵公司属于哪一种?当日关注点交易信息汇总:8月12日主力资金净流入296.8万元,占总成交额6.41%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300001242.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002022","BK0046","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658927440","title":"科华生物:持续推进全价值链降本增效","url":"https://stock-news.laohu8.com/highlight/detail?id=2658927440","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658927440?lang=zh_cn&edition=full","pubTime":"2026-08-12 16:09","pubTimestamp":1786522147,"startTime":"0","endTime":"0","summary":"面对IVD行业集采政策持续落地执行、DRG/DIP支付方式加速落地、检验结果互认范围扩大、检验收费价格调整等多重政策压力及竞争加剧的市场环境,公司积极应对、主动调整,一方面,公司近年来持续推进全价值链降本增效,通过调整组织架构、精益管理优化资源配置效率,推动经营管理数智化转型,充分释放提质增效潜力,提升整体运营效能。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200025680.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","BK0028","BK0188","002022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657865453","title":"股市必读:科华生物新发布《关于产品获得医疗器械注册证的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657865453","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657865453?lang=zh_cn&edition=full","pubTime":"2026-08-07 02:40","pubTimestamp":1786041624,"startTime":"0","endTime":"0","summary":"截至2026年8月6日收盘,科华生物报收于5.22元,上涨0.77%,换手率0.9%,成交量4.61万手,成交额2388.46万元。公司公告汇总关于产品获得医疗器械注册证的公告上海科华生物工程股份有限公司收到国家药品监督管理局颁发的医疗器械注册证,产品为淋球菌核酸检测试剂盒,注册证编号国械注准20263401679,有效期至2031年8月3日。该试剂盒用于体外定性检测男性尿道拭子、女性宫颈拭子样本中的淋球菌核酸。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700002270.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159883","002022","BK1583","BK0188","BK0239","BK1574","BK0028","BK0046","BK1100","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657435523","title":"科华生物(002022)披露产品获得医疗器械注册证公告,8月5日股价下跌0.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657435523","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657435523?lang=zh_cn&edition=full","pubTime":"2026-08-05 22:34","pubTimestamp":1785940458,"startTime":"0","endTime":"0","summary":"截至2026年8月5日收盘,科华生物报收于5.18元,较前一交易日下跌0.96%,最新总市值为26.65亿元。该股当日开盘5.24元,最高5.28元,最低5.16元,成交额达3369.35万元,换手率为1.26%。近日,上海科华生物工程股份有限公司收到国家药品监督管理局颁发的医疗器械注册证,产品为淋球菌核酸检测试剂盒,注册证编号国械注准20263401679,有效期至2031年8月3日。该试剂盒用于体外定性检测男性尿道拭子、女性宫颈拭子样本中的淋球菌核酸。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500043659.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK1583","09996","BK0239","BK1100","BK1574","BK0028","002022","159883","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657951126","title":"连续三年亏损叠加股价较高点最大跌幅超八成,科华生物拟推股权激励计划和员工持股计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2657951126","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657951126?lang=zh_cn&edition=full","pubTime":"2026-08-05 16:25","pubTimestamp":1785918300,"startTime":"0","endTime":"0","summary":"由于业绩持续下滑,科华生物的股价也持续走弱。相较于约六年前的高点,科华生物股价最大跌幅超过80%。2026年8月4日晚,科华生物发布了2026年限制性股票激励计划(草案)和2026年员工持股计划(草案)。若科华生物股权激励计划和员工持股计划皆按照上限成功实施且获得解锁,那么以8月4日收盘价计算,6位激励对象和220位核心员工所持股票浮盈规模将接近9000万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-08-05/doc-inimhawc3617532.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-08-05/doc-inimhawc3617532.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","002022","BK0188","BK0028","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657563785","title":"股市必读:科华生物新发布《2026年限制性股票激励计划考核管理办法》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657563785","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657563785?lang=zh_cn&edition=full","pubTime":"2026-08-05 02:08","pubTimestamp":1785866893,"startTime":"0","endTime":"0","summary":"公司公告汇总2026年限制性股票激励计划考核管理办法《2026年限制性股票激励计划考核管理办法》适用于公司董事、高级管理人员及其他核心员工,首次授予激励对象不超过6人。2026年员工持股计划管理办法2026年员工持股计划存续期为60个月。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500001965.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002022","BK0239","BK0046","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656377141","title":"科华生物(002022)披露2026年限制性股票激励计划(草案),8月3日股价上涨1.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656377141","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656377141?lang=zh_cn&edition=full","pubTime":"2026-08-03 22:36","pubTimestamp":1785767780,"startTime":"0","endTime":"0","summary":"截至2026年8月3日收盘,科华生物报收于5.16元,较前一交易日上涨1.38%,最新总市值为26.54亿元。近日,科华生物披露《2026年限制性股票激励计划(草案)》。公告显示,该激励计划股票来源为定向增发A股普通股,授予总量2,000.00万股,占公司股本总额的3.89%。其中首次授予1,700.00万股,激励对象不超过6人,包括公司董事、高级管理人员;预留300.00万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300037600.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","BK0239","002022","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654830388","title":"科华生物(002022)披露“科华转债”到期兑付结果及股本变动公告,7月28日股价上涨1.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654830388","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654830388?lang=zh_cn&edition=full","pubTime":"2026-07-28 22:46","pubTimestamp":1785249971,"startTime":"0","endTime":"0","summary":"截至2026年7月28日收盘,科华生物报收于5.02元,较前一交易日上涨1.41%,最新总市值为25.82亿元。近日,上海科华生物工程股份有限公司披露《关于“科华转债”到期兑付结果及股本变动的公告》。公告显示,公司于2026年7月28日完成“科华转债”到期兑付,兑付数量为2,235,726张,兑付金额为236,986,956.00元,兑付资金已发放,“科华转债”已于同日摘牌。本次股本变动后,公司总股本由514,355,133股增至514,397,174股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072800040203.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","002022","BK0028","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652110802","title":"科华生物(002022)披露“科华转债”到期兑付及摘牌公告,7月20日股价下跌0.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652110802","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652110802?lang=zh_cn&edition=full","pubTime":"2026-07-20 22:37","pubTimestamp":1784558230,"startTime":"0","endTime":"0","summary":"截至2026年7月20日收盘,科华生物报收于5.09元,较前一交易日下跌0.97%,最新总市值为26.18亿元。该股当日开盘5.08元,最高5.22元,最低4.99元,成交额达4844.21万元,换手率为1.85%。近日,上海科华生物工程股份有限公司发布公告,宣布“科华转债”将于2026年7月27日到期,兑付登记日为当日,到期兑付价格为106元/张,兑付资金发放日为2026年7月28日。截至到期日未转股的债券将被强制赎回并摘牌,摘牌日为2026年7月28日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000039870.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","BK0239","BK0046","002022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651124174","title":"科华生物:预计2026年1-6月扣非后净利润亏损9300万元至1.28亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651124174","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651124174?lang=zh_cn&edition=full","pubTime":"2026-07-14 18:09","pubTimestamp":1784023767,"startTime":"0","endTime":"0","summary":"证券之星消息,科华生物发布业绩预告,预计2026年1-6月扣非后净利润亏损9300万元至1.28亿元。上海科华生物工程股份有限公司董事会2026 年 7 月 15 日科华生物2026年一季报显示,一季度公司主营收入3.95亿元,同比上升1.86%;归母净利润-4845.13万元,同比上升9.03%;扣非净利润-5138.4万元,同比上升9.27%;负债率32.9%,投资收益169.83万元,财务费用885.24万元,毛利率36.81%。本文数据来源于《科华生物:2026年半年度业绩预告》,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400037603.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648645726","title":"科华生物(002022)披露产品获得医疗器械注册证公告,7月3日股价上涨2.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648645726","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648645726?lang=zh_cn&edition=full","pubTime":"2026-07-03 22:59","pubTimestamp":1783090752,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘,科华生物报收于4.88元,较前一交易日上涨2.95%,最新总市值为25.1亿元。该股当日开盘4.8元,最高4.9元,最低4.72元,成交额达3512.28万元,换手率为1.42%。近日,上海科华生物工程股份有限公司收到上海市药品监督管理局颁发的医疗器械注册证,产品为补体C1q测定试剂盒,注册证编号沪械注准20262400242,有效期自2026年06月30日至2031年06月29日,适用于体外定量测定人体血清、血浆中补体C1q的含量。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070300046175.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002022","BK0188","BK1100","BK1574","09996","BK0239","BK0046","159883","BK1583","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648365104","title":"科华生物(002022.SZ):补体C1q测定试剂盒(胶乳免疫比浊法)获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2648365104","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648365104?lang=zh_cn&edition=full","pubTime":"2026-07-03 16:06","pubTimestamp":1783065980,"startTime":"0","endTime":"0","summary":"智通财经APP讯,科华生物(002022.SZ)发布公告,公司收到上海市药品监督管理局颁发的医疗器械注册证(体外诊断试剂),该产品为:“补体C1q测定试剂盒(胶乳免疫比浊法)”,该试剂盒供医疗机构用于体外定量测定人体血清、血浆中补体C1q的含量。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1462856.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002022","09996","BK0239","BK0046","BK0188","BK1574","BK1583","159883","BK0028","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648544845","title":"科华生物(002022)披露产品获得医疗器械注册证的公告,7月1日股价上涨3.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648544845","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648544845?lang=zh_cn&edition=full","pubTime":"2026-07-01 22:56","pubTimestamp":1782917773,"startTime":"0","endTime":"0","summary":"截至2026年7月1日收盘,科华生物报收于4.74元,较前一交易日上涨3.49%,最新总市值为24.38亿元。该股当日开盘4.57元,最高4.8元,最低4.51元,成交额达3931.56万元,换手率为1.63%。近日,上海科华生物工程股份有限公司及控股子公司苏州天隆生物科技有限公司收到上海市药品监督管理局和国家药品监督管理局颁发的医疗器械注册证。上述产品注册证的取得将丰富公司产品线,对公司业务发展具有正面影响,但公司尚无法预测其对未来营业收入的影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100043750.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","159883","BK1583","BK1574","09996","002022","BK1100","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646365008","title":"科华生物(002022)披露“科华转债”即将到期及停止交易的第三次提示性公告,6月26日股价下跌3.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646365008","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646365008?lang=zh_cn&edition=full","pubTime":"2026-06-26 22:52","pubTimestamp":1782485537,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘,科华生物报收于4.6元,较前一交易日下跌3.36%,最新总市值为23.66亿元。近日,上海科华生物工程股份有限公司发布《关于“科华转债”即将到期及停止交易的第三次提示性公告》。公告显示,科华转债到期日为2026年7月27日,到期兑付金额为106元/张。最后交易日为2026年7月22日,自7月23日起停止交易。截至7月27日收市仍未转股的债券将被强制赎回并摘牌。公司将在指定媒体发布到期兑付及摘牌公告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600046071.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002022","BK0188","BK0239","BK0028","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645891680","title":"科华生物(002022)披露“科华转债”即将到期及停止交易的第二次提示性公告,6月24日股价下跌3.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645891680","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645891680?lang=zh_cn&edition=full","pubTime":"2026-06-24 17:57","pubTimestamp":1782295065,"startTime":"0","endTime":"0","summary":"截至2026年6月24日收盘,科华生物报收于4.91元,较前一交易日下跌3.16%,最新总市值为25.25亿元。该股当日开盘5.08元,最高5.11元,最低4.86元,成交额达3553.06万元,换手率为1.4%。近日,上海科华生物工程股份有限公司发布公告,提醒“科华转债”持有人注意相关到期及停止交易安排。最后交易日为2026年7月22日,自2026年7月23日起停止交易。最后转股日为2026年7月27日,截至当日收市后未转股的债券将被强制赎回并摘牌。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400033739.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002022","BK0188","BK0046","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645788922","title":"科华生物:西安天隆科技为公司合并报表范围内控股子公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2645788922","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645788922?lang=zh_cn&edition=full","pubTime":"2026-06-23 16:18","pubTimestamp":1782202692,"startTime":"0","endTime":"0","summary":"证券之星消息,科华生物(002022)06月23日在投资者关系平台上答复投资者关心的问题。投资者提问:天隆科技卖血站核酸血筛试剂了是不是?那不是跟科华同业竞争了吗?科华生物回复:尊敬的投资者,您好!西安天隆科技为公司合并报表范围内控股子公司,同属上市公司体系内经营,体系内母子公司不存在同业竞争。公司统筹规划分子诊断业务布局,形成内部业务协同、渠道互补,统一对外参与市场竞争,不存在利益冲突。公司及子公司经营严格遵守上市规则与公司内控制度。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300026873.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002022","BK0188","BK0028","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645107372","title":"科华生物(002022)披露“科华转债”即将到期及停止交易的第一次提示性公告,6月22日股价下跌0.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645107372","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645107372?lang=zh_cn&edition=full","pubTime":"2026-06-22 22:46","pubTimestamp":1782139581,"startTime":"0","endTime":"0","summary":"截至2026年6月22日收盘,科华生物报收于4.89元,较前一交易日下跌0.81%,最新总市值为25.15亿元。该股当日开盘4.91元,最高4.92元,最低4.7元,成交额达3598.87万元,换手率为1.46%。近日,上海科华生物工程股份有限公司发布公告,提醒“科华转债”持有人注意相关到期及停止交易安排。最后交易日为2026年7月22日,自2026年7月23日起停止交易。最后转股日为2026年7月27日,截至当日收市后未转股的债券将被强制赎回并摘牌。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200039141.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002022","BK0188","BK0046","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645016934","title":"股市必读:科华生物(002022)6月18日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2645016934","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645016934?lang=zh_cn&edition=full","pubTime":"2026-06-22 04:40","pubTimestamp":1782074421,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘,科华生物报收于4.93元,上涨0.41%,换手率1.0%,成交量5.15万手,成交额2542.37万元。若公司存在应披露的重大事项,公司将严格按照法律法规的规定及时履行信息披露义务,请以公司披露的公告为准。当日关注点交易信息汇总:6月18日主力资金净流出230.53万元,游资资金净流入98.99万元,散户资金净流入131.54万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200001592.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002022","BK0046","BK0239","BK0028","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645709616","title":"每周股票复盘:科华生物(002022)主体信用等级被下调至A","url":"https://stock-news.laohu8.com/highlight/detail?id=2645709616","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645709616?lang=zh_cn&edition=full","pubTime":"2026-06-21 03:18","pubTimestamp":1781983092,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘,科华生物报收于4.93元,较上周的5.08元下跌2.95%。本周,科华生物6月15日盘中最高价报5.17元。本周关注点公司公告汇总:联合资信评估下调科华生物主体长期信用等级为A,“科华转债”信用等级同步下调至A,评级展望为稳定。评级下调主要受2025年集采政策等因素影响,公司营业总收入下降,利润亏损加剧,EBITDA为负,偿债能力弱化。但“科华转债”即将兑付,现金类资产对其保障程度高,债务负担较轻。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062100001070.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","002022","BK0028","BK0239","BK0046"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1786724468047,"stockEarnings":[{"period":"1week","weight":0.0737},{"period":"1month","weight":0.0902},{"period":"3month","weight":-0.0122},{"period":"6month","weight":-0.0734},{"period":"1year","weight":-0.2314},{"period":"ytd","weight":-0.0438}],"compareEarnings":[{"period":"1week","weight":-0.0033},{"period":"1month","weight":-0.0072},{"period":"3month","weight":-0.0503},{"period":"6month","weight":-0.0379},{"period":"1year","weight":0.0711},{"period":"ytd","weight":-0.0105}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海科华生物工程股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"154660人(较上一季度增加219.88%)","perCapita":"3325股","listingDate":"2004-07-21","address":"上海市徐汇区钦州北路1189号","registeredCapital":"51439万元","survey":" 上海科华生物工程股份有限公司的主营业务是体外诊断试剂、仪器的研发、生产和销售。公司的主要产品是体外诊断试剂、仪器。公司及子公司曾获得“国家科技进步二等奖”“国家高新技术企业”“国家知识产权示范企业”“国家发改委生物医学工程高技术产业化示范企业”“中国中小企业创新100强”“上海市著名商标证书”“上海名牌”“上海市科学技术奖”“上海市创新型企业”“陕西省和西安市创新型企业”“陕西省院士工作站”等荣誉,并多次入选上海百强企业多项榜单。","listedPrice":11.12},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科华生物(002022)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科华生物(002022)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科华生物,002022,科华生物股票,科华生物股票老虎,科华生物股票老虎国际,科华生物行情,科华生物股票行情,科华生物股价,科华生物股市,科华生物股票价格,科华生物股票交易,科华生物股票购买,科华生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科华生物(002022)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科华生物(002022)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}